German pharmaceutical and chemical giant Bayer completed its 63 billion dollar acquisition of American agrochemical and seed company Monsanto in June 2018, creating the world's largest supplier of seeds and pesticides. The deal, retiring the controversial Monsanto name, saddled Bayer with tens of billions of dollars in liabilities from tens of thousands of lawsuits alleging Monsanto's Roundup weedkiller causes cancer, badly damaging Bayer's share price for years afterward.
Facts
Cross-Tradition Connections
Associated With
Monsanto, the acquired company, was a leading agricultural seed and agrochemical firm, making the merger a landmark event in the agriculture industry's consolidation.
The Bayer 2018 acquisition of Monsanto, financed with a large debt-funded cash offer, is a finance-practice case study in cross-border acquisition financing and post-merger liability risk.
Sources
Reader Challenges (0 open reader challenges)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
The atlas records no dated fact of its own for this entry, so there is no other year to choose.